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A plasmonic multi-logic gate platform based on
sequence-speciﬁc binding of estrogen receptors
and gold nanorods†
Roger M. Pallares,a,b Michel Bosman,b Nguyê˜n T. K. Thanh*c,d and Xiaodi Su*b
A hybrid system made of gold nanorods (AuNRs) and double-
stranded DNA (dsDNA) is used to build a versatile multi-logic gate
platform, capable of performing six diﬀerent logic operations. The
sequence-speciﬁc binding of transcription factors to the DNA
drives the optical response of the design.
One of the most promising applications of nanotechnology is
building molecular-scale logic gates, capable of performing
logic operations on external inputs.1,2 These new logic gates are
candidates for new computing revolution and miniaturization
of information technology at the nanoscale.3 To date, most
molecular logic gate designs are based on fluorescence
signals4–6 and chemically demanding modifications of nano-
materials7 and/or biomolecules,6,8–10 which increase design
complexity and resource investment. Recently, gold nano-
particles (AuNPs) have been used as building blocks for colouri-
metric logic gates11–15 due to their high extinction coeﬃcients
and interparticle-distance dependent optical properties,16 which
can be easily monitored by UV-visible spectroscopy.
Even though the existing AuNP-based logic gate designs
present promising results, they have several drawbacks, such
as complex surface modifications,11,12 multiple separation and
purification steps,12 lack of versatility to build several logic
gates13,14 and/or use of strong toxic ligands.13–15 Nowadays,
great eﬀorts are being made in bioinspired materials research
to mimic nature’s high dynamic control over nanomaterial
assembly, with an excellent spatial and temporal resolution
upon a biological input.17 Following this strategy, several logic
gate designs have recently been published, exploiting bio-
chemical events, such as antibody recognition,10 DNA hybrid-
ization,9,18 DNA assembly,19 catalytic reactions by DNAzymes20
or peptide interactions.21
The logic system that we present in this work is able to go a
step further. To the best of our knowledge, this is the first
design to mimic the gene regulation performed by transcrip-
tion factors as a biochemical event for the logic response.
Furthermore, this design overcomes the lack of versatility of
most designs and can perform six diﬀerent logic operations,
while no complex surface modification is required. Multi-logic
gate platforms capable of performing six logic operations are
very rare and just few have been published.19,21
The mechanism of this multi-logic gate platform relies on
the binding of estrogen receptors (ERs) to dsDNA adsorbed on
gold nanorods (Scheme 1). ERs are a group of transcription
factors activated by estrogen22 (i.e. steroid hormone that regu-
lates several functions including the development of the repro-
ductive system and maintenance of the bone structure). ER’s
action involves binding to specific DNA sequences, called
estrogen receptor elements (EREs), that trigger the estrogen
Scheme 1 Schematic illustration of one of the logic gates, i.e. OR, per-
formed by the multi-logic gate design. OR logic gate is built by combin-
ing dsDNA-AuNRs and ERs, exploiting sequence-speciﬁc interactions
between ERs and dsDNA.
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biological response.23 The dsDNA used in this work is 35
base-pair long and contains the ERE consensus sequence
(GGTCAnnnTGACC, where n are spacer nucleotides), which
provides binding specificity for ERs (i.e. ERα and ERβ). AuNRs
with an aspect ratio of 4.1 were synthesized by a seed-mediated
method (Fig. S1†).24 Hexadecyltrimethylammonium bromide
was used as the surfactant, which provides positive charges to
the surface of nanorods. We recently proved that when posi-
tively charged AuNRs are mixed with negatively charged
dsDNA, the nucleic acid molecules are adsorbed on the nano-
particle surface (dsDNA-AuNR), changing the electric potential
of the particles.25 The variation of the surface charge of the
rods triggers the nanoparticle aggregation at lower dsDNA con-
centrations and disaggregation at higher concentrations.
Fig. 1A presents the red shift of the AuNR longitudinal
localised surface plasmon resonance (L-LSPR) band by the
addition of dsDNA from 0 to 20 nM (Au0 concentration of
257 μM). Interestingly, a further increase of dsDNA, i.e. from
20 to 100 nM, blue shifts the L-LSPR band (Fig. 1B). In a plot
of the absorbance ratio at the two plasmon band maxima wave-
lengths (A510/A885) versus dsDNA concentration (Fig. 1C), the
lower (blue circles) and the higher (red squares) concentration
regimes are clearly observed. Dynamic light scattering charac-
terization (DLS, Fig. S2†) confirms the initial rod aggregation
and later disaggregation, which accounts for the increase and
decrease of A510/A885 values in Fig. 1C, respectively. DLS data
show the increase of the rod hydrodynamic diameter from
55 nm up to 3803 nm after the addition of 20 nM dsDNA. The
initial dispersity, measured by the initial particle size, is
almost fully recovered at 100 nM dsDNA, where the hydro-
dynamic diameter decreases to 64 nm. The change of the AuNR’s
surface charge as a driving force behind the two-concentration
regime behaviour25 is further verified by zeta potential analysis
(Fig. S2†). AuNRs are initially positively charged (30.4 mV). The
addition of dsDNA starts neutralizing the surface charge by
electrostatic screening, decreasing the electrostatic repulsion
among the particles. This induces nanorod aggregation, which
reaches its maximum when the surface charge is neutralized
at around 20 nM dsDNA. Further additions of dsDNA induce a
charge reversal and increase of the negative charge, which
restores a part of the electrostatic repulsion among the par-
ticles and disassembles them, reaching a zeta potential of
−22.6 mV at 100 nM dsDNA.
Two human ER subtypes (i.e. ERα and ERβ) and one non-
ERE-binding protein (i.e. lysozyme) are used in the logic
system. ERα and ERβ have an isoelectric point (pI) of 8.3 and
8.8, respectively,26 and they are sold and stored in Tris 50 mM
buﬀer (pH 8 and 9, respectively). When 50 mM (pH 8) Tris
without ERs is added to the dsDNA-AuNR solutions, the nano-
particles slightly aggregate over time (Fig. S3†). After an incu-
bation of 40 min, the absorbance ratios are mostly stable, indi-
cating that no further aggregation significantly occurs due to
the buﬀer. Thus, incubation times of 40 min are chosen for all
protein-binding experiments to equalize the buﬀer eﬀects. The
binding of ERα to dsDNA-AuNR is initially studied. Due to the
diﬀerent electrokinetic behaviour of dsDNA-AuNR at lower and
higher dsDNA concentration regimes, the ERα binding is
studied at two DNA concentrations of 10 nM (lower concen-
tration regime) and 75 nM (higher concentration regime).
Fig. 2A and B present increasing A510/A885 (increased aggrega-
tion) upon ERα binding at the respective dsDNA con-
centrations. Both figures show that the ERα binds to the ERE-
containing dsDNA with a stoichiometry of 2 to 1, i.e. A510/A885
reaches saturation at 2 : 1 of the ERα:dsDNA concentration
ratio. This is in agreement with the previously published litera-
ture that reports ERα binding to ERE as a dimer.27 The proper
binding stoichiometry and the negligible aﬃnity of ERα for
control DNA molecules, where the ERE binding site is
scrambled,28,29 support the fact that ERα interacts with DNA
through sequence-specific binding, inducing AuNR aggrega-
tion. We hypothesize that the aggregation is driven by the
interprotein interactions. At pH close to the protein’s pI (solu-
Fig. 1 Characterization of AuNRs mixed with diﬀerent amounts of
dsDNA. (A) UV-Vis spectra of the AuNRs in the presence of 0, 5, 10 and
20 nM DNA. (B) UV-Vis spectra in the presence of 30, 40, 50, 75 and 100
nM DNA. (C) Absorbance intensity ratio at 510 and 885 nm as a function
of DNA concentration. The lower and higher concentration regimes are
highlighted in blue circles and red squares, respectively. 10 nM at the
lower concentration regime and 75 nM at the higher concentration
regime are indicated because these two concentrations are used in the
protein–DNA binding characterization experiments.
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tions pH ∼ 8.0), the van der Waals and dipole–dipole attractive
forces dominate over the charge–charge electrostatic repulsion
forces (i.e. the protein’s charge is almost neutralised at pH
near their pI).30 Therefore, proteins tend to aggregate at these
pH values, driving the aggregation of the nanoparticles bound
to them. It is worth mentioning that several studies have
reported that the interprotein interactions between ERα and
other transcription factors are strong and play a key role in the
ERα gene regulation.31–33
Even though the DNA-binding domains of ERα and ERβ are
highly conserved (96% identity),34 their binding behaviour to
ERE presents a significant diﬀerence. Fig. S4† shows the plots
of the binding curve of ERβ to ERE-containing dsDNA on
AuNRs at pH ∼ 8.5, using the A510/A885 ratio as the binding
signal. The transcription factor induces the aggregation of
dsDNA-AuNR as previously observed for ERα, i.e. increasing
the A510/A885 ratio. Nevertheless the stoichiometry between ERβ
and ERE is approximately 4 to 1. This observation is in agree-
ment with previous reports, which studied the ERβ–ERE
binding by surface plasmon resonance spectroscopy.35
To further aﬃrm the role of sequence-specific protein–DNA
binding, a non-ERE-binding protein, lysozyme, is used.
Fig. S5A and S5B† show the plot of the A510/A885 variation
versus lysozyme concentration at 10 nM and 75 nM dsDNA,
respectively, as carried out for ERα experiments. At 10 nM
dsDNA, the addition of lysozyme barely changes the A510/A885
(Fig. S5A†). We hypothesize that dsDNA-AuNR and lysozyme
electrostatically repel each other because of their positive
charges (i.e. lysozyme presents a pI of 11.2 36 and it is posi-
tively charged at the pH ∼ 8.0 of this study). On the other
hand, a moderate increase of A510/A885 (moderate aggregation
increase) upon increase in the lysozyme concentration is
observed at 75 nM (Fig. S5B†). This is because dsDNA-AuNRs
are negatively charged at 75 nM and the electrostatic inter-
action between dsDNA-AuNRs and lysozyme is favoured.
Interestingly, ERs (sequence-specific binding) and lysozyme
(electrostatic interactions) present diﬀerent nanoparticle aggre-
gation behaviours, which are more distinguishable at low
dsDNA concentrations. Therefore, the lower dsDNA concen-
tration regime is exploited to build the platform capable of
performing logic operations at the nanoscale.
We build logic gates by adding proteins or dsDNA (logic
inputs) into a base solution consisting of AuNR (Au0 concen-
tration of 257 μM) and dsDNA of 10 nM (leading to dispersed
AuNRs) or 25 nM (leading to aggregated AuNRs). The logic
values of the inputs are 0 and 1, which are defined as the
absence and the presence of the input in solution, respectively.
The outputs are read by measuring the variation in the A510/
A880 ratio, where the logic values 0 and 1 are experimentally
established as 0.65 and 0.75, respectively. The amount of input
added into the solutions was experimentally optimized, so that
the output signals are coherent in all the logic gates. First, the
logic gate OR is built (Fig. 3A). The base solution contains
AuNRs and dsDNA (10 nM), and the two inputs are ERα (20
nM) and ERβ (30 nM). Both inputs induce a similar level of
aggregation when separately added (0/1 and 1/0). Interestingly,
when both ERs are added at the same time (1/1), a similar
level of aggregation is obtained, rather than a higher one. This
is most likely because the amount of ERE-containing dsDNA is
the limiting factor. Thus, the excess of ERs does not bind to
the dsDNA and it is left in solution without interacting with
the nanoparticles. Next, the NOT gate is designed (Fig. 3B). It
is a 1-input 1-output gate that performs logic negation. The
base solution contains AuNRs and 25 nM dsDNA, which aggre-
gates the nanoparticles (0/0). When more dsDNA (additional
15 nM) is added as an input in a second step, the nano-
particles disaggregate (1/1). OR and NOT are basic operations
and all the rest can be obtained by combining them (e.g.
through cascade reactions21). Nevertheless, it is worth men-
tioning that our system allows the direct building of derivative
operations without the need for combining basic operations.
First, the A IMPLY B gate is developed by using a base solution
with AuNRs and 25 nM dsDNA (Fig. 3C). The two inputs are
dsDNA (additional 15 nM) and ERβ (30 nM). In the initial state
(0/0), the nanoparticles are aggregated. When more dsDNA is
added (1/0), the new dsDNA triggers AuNR disassembly. The
single addition of ERβ (0/1) does not change the aggregation
state of the nanoparticles because they are already aggregated.
The addition of both inputs (1/1) results in AuNR aggregation,
since dsDNA’s disassemble capacity is compensated by ERβ
aggregating behaviour. Next, the BUFFER logic gate is demon-
strated. A base solution made of AuNRs and 10 nM dsDNA,
and one input (20 nM ERα) are required (Fig. 3D). The mech-
anism of this gate is based on the further aggregation of
dsDNA-AuNR induced by ERα (1). The TRUE logic gate can
also be obtained. This is constructed by using a base solution
of AuNRs and 25 nM dsDNA (Fig. 3E). The two inputs are ERα
Fig. 2 AuNR absorbance intensity ratio at 510 and 885 nm as a function
of ERα concentration at (A) 10 and (B) 75 nM dsDNA.
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(20 nM) and ERβ (30 nM). Since the nanoparticles are already
aggregated in the initial state (0/0), the addition of ERs does
not significantly change the aggregation state of the system.
Lastly, the FALSE gate is built (Fig. 3F). The base solution con-
tains AuNRs and 10 nM dsDNA, and the inputs are lysozyme
(20 nM) and dsDNA (additional 27 nM). In the initial state, the
AuNRs are dispersed (0/0). Lysozyme does not interact with
ERE-containing dsDNA, and its addition (1/0) does not aﬀect
the aggregation state. The addition of extra 27 nM dsDNA keeps
the nanoparticles disaggregated (0/1 and 1/1). Based on the pre-
vious zeta potential results, we hypothesize that the amount of
dsDNA in solution is enough to induce a nanoparticle charge
reversal and provide enough electrostatic repulsion to disaggre-
gate the AuNRs. It is worth mentioning that even though this is
a multi-component system, the sequence-specific binding is
essential for building four of the six logic gates (i.e. OR, A
IMPLY B, BUFFER and TRUE). A limited number of logic oper-
ations (i.e. NOT and FALSE) can be performed by using only
dsDNA and/or non-specific binding protein as inputs.
Finally, the results from the logic gate experiments are stat-
istically assessed, rendering two conclusions: (1) All the A510/
A885 outputs are successfully labelled as logic 0 or 1 values,
since they are not statistically diﬀerent from one of the two
reference values, i.e. 0.65 and 0.75, respectively (p > 0.05,
Table S1); (2) the values for logic 0 are statistically diﬀerent
and clearly distinguishable from the values for logic 1 (p <
0.05, Table S2; Cohen’s d > 3.5, Table S3†).
In summary, we have developed a plasmonic hybrid system
made of AuNR and ERE-containing dsDNA capable of tracking
the binding of ERs (i.e. ERα and ERβ) to their response
element. The system is sensitive enough to distinguish
between protein isomorphs. The mechanism is based on the
interprotein interactions among ERs, which are bound to
dsDNA on the surface of AuNRs under sequence recognition,
and trigger nanoparticle’s aggregation. The combination of
proteins, ERE-containing dsDNA, AuNRs and the interactions
among them allow expanding the system to a plasmonic logic
gate platform, becoming the first system that performs logic
operations by mimicking transcription factor’s gene regu-
lation. This versatile system is able to perform 6 diﬀerent logic
operations (i.e. OR, NOT, A IMPLY B, BUFFER, TRUE and
FALSE) by changing the design set-up. This overcomes one of
the main limitations of traditional nanoscale logic gates,
which are just able to perform few logic operations with the
same platform. Furthermore, this system is conceptually
simple, easy-to-use and does not require complex surface
modifications, toxic ligands or separation/purification steps.
Based on these results, two diﬀerent directions can be envi-
sioned in order to expand the performance of the multi-logic
gate platform: (1) the combination of diﬀerent logic gates
through cascade reactions, which could result in more
complex logic operations, such as the combination of OR and
NOT to obtain the universal gate NOR (Scheme 2). (2) It is
expected that the combination of this nanomaterial-based
Fig. 3 AuNR absorbance ratio intensities at 510 and 885 nm as a function of diﬀerent inputs in (A) OR, (B) NOT, (C) A IMPLY B, (D) BUFFER, (E) TRUE
and (F) FALSE logic gates.
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method with microfluidic technologies could result in a lab-on-
chip device capable of resetting the system for several consecu-
tive operations. Lastly, these new insights into the spatial and
temporal control over nanomaterial assembly by transcription
factors can be the first steps for other nanoscale technologies,
such as transcription factor-mediated smart drug release.
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